
Simvastatin treatment reduces heat shock protein 60, 65, and 70 antibody titers in dyslipidemic patients: A randomized, double-blind, placebo-controlled, cross-over trial
Keywords: پروتئین شوک حرارت; Simvastatin; Heat shock protein; Antibody; C-reactive protein; Cross-over study